Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza
- 11 February 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (7), 1087-1092
- https://doi.org/10.1016/j.vaccine.2008.11.108
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responsesVaccine, 2007
- Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza VaccineJama-Journal Of The American Medical Association, 2007
- Dose‐Related Safety and Immunogenicity of a Trivalent Baculovirus‐Expressed Influenza‐Virus Hemagglutinin Vaccine in Elderly AdultsThe Journal of Infectious Diseases, 2006
- Preparing for the Next PandemicThe New England Journal of Medicine, 2005
- Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessmentVaccine, 2005
- Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults.Human Vaccines, 2005
- The role of cell culture vaccines in the control of the next influenza pandemicExpert Opinion on Biological Therapy, 2004
- The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccinesVaccine, 2001
- Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humansVaccine, 2001
- Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin.Proceedings of the National Academy of Sciences of the United States of America, 1986